Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06680180

Fibrinolysis Resistance in Infection and Trauma

Led by Anders Aneman · Updated on 2024-11-08

150

Participants Needed

4

Research Sites

104 weeks

Total Duration

On this page

Sponsors

A

Anders Aneman

Lead Sponsor

L

Liverpool Hospital, South Western Sydney Local Health District

Collaborating Sponsor

AI-Summary

What this Trial Is About

Blood coagulation disorders are often seen in critically ill patients e.g. with severe infection or following extensive injury, that can lead to life threatening events as a result of excessive blood clot formation leading to organ failure. This study aims to use Viscoelastic Testing (VET) technology to detect patients at risk of excessive blood blot formation at the bedside, test new blood coagulation drugs, and guide life-saving use of blood modifying treatments.

CONDITIONS

Official Title

Fibrinolysis Resistance in Infection and Trauma

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • For sepsis/septic shock group: admitted to ICU needing at least one organ support and mainly for clinically suspected sepsis or septic shock (including SARS-COV-2)
  • Expected to stay in ICU and survive beyond the day after next
  • For trauma group: trauma as the main diagnosis on ICU admission
  • Expected to stay in ICU and survive beyond the day after next
  • Receiving respiratory support such as high-flow nasal prongs, non-invasive or invasive ventilation at ICU admission
  • Already received or at risk of needing blood transfusion within 24 hours of injury
Not Eligible

You will not qualify if you...

  • Currently taking oral anticoagulant or antiplatelet therapy
  • Not receiving full, active ICU support
  • Death expected within 24 hours
  • For trauma group: nursing home resident
  • Unsurvivable head injury

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

The Canberra hospital (ICU)

Canberra, Australian Capital Territory, Australia, 2605

Actively Recruiting

2

Liverpool Hospital (ICU)

Liverpool, New South Wales, Australia, 2170

Actively Recruiting

3

Macquarie University Hospital (ICU)

Macquarie, New South Wales, Australia, 2109

Actively Recruiting

4

Royal North Shore Hospital (ICU)

St Leonards, New South Wales, Australia, 2065

Actively Recruiting

Loading map...

Research Team

A

Anders Aneman, MD, PhD, EDIC, FCICM

CONTACT

L

Lucy Coupland, Nurs Cert, BSci (hons), PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here